Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: A phase 1/2 trial Meeting Abstract
| Authors: | Nassiri, F.; Patil, V.; Yefet, L.; Singh, O.; Liu, J.; Dang, R.; Yamaguchi, T.; Daras, M.; Cloughesy, T.; Colman, H.; Kumthekar, P.; Chen, C.; Aiken, R.; Groves, M.; Ong, S.; Ramakrishna, R.; Vogelbaum, M. A.; Khagi, S.; Kaley, T.; Melear, J.; Peereboom, D.; Rodriguez, A.; Yankelevich, M.; Nair, S.; Puduvalli, V.; Aldape, K.; Gao, A.; Lopez-Janeiro, A.; de Andrea, C.; Alonso, M.; Boutros, P.; Robbins, J.; Mason, W.; Sonaben, A.; Stupp, R.; Fueyo-Margareto, J.; Gomez-Manzano, C.; Lang, F.; Zadeh, G. |
| Abstract Title: | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: A phase 1/2 trial |
| Meeting Title: | 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 25 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Nov 15-19 |
| Meeting Location: | Vancouver, Canada |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | v65 |
| End Page: | v66 |
| Language: | English |
| ACCESSION: | WOS:001115245400260 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noad179.0259 |
| Notes: | Meeting Abstract: CTIM-19 -- Source: Wos |
